The lab of Terry Hinds, Ph.D., is advancing scientific discovery at UK, and also helping undergraduate students, graduate students and postdoctoral fellows gain early experience with high-impact work.
While cancer survivors have an increased risk of developing cancer in the future, that risk is notably higher in Kentucky and Appalachian Kentucky, according to a new University of Kentucky Markey Cancer Center study.
The Kentucky Statewide EPSCoR Committee, the governing body of the state’s National Science Foundation Established Program to Stimulate Competitive Research (EPSCoR) program voted to adopt the Kentucky Science & Technology Plan: Vision 2030.
Using antibodies derived from alpacas, a University of Kentucky research team has developed a tool that could lead to new therapies to stop the growth of several types of cancer.
The inaugural cohort of President Biden’s Cancer Moonshot Scholars includes University of Kentucky Markey Cancer Center researcher Laurie McLouth, Ph.D.
A Markey Cancer Center research team identified an existing cancer drug that shows promise as a treatment for the most common type of non-small cell lung cancer.
A recent study published in The Journal of Rural Health sheds light on Appalachian Kentucky’s alarming cancer burden, revealing striking disparities compared to non-Appalachian Kentucky and the rest of the country.
Established by a Kentucky Senate Joint Resolution (SJR 79) during the 2023 regular session, the workgroup is led by Kentucky’s Energy and Environment Cabinet.
Over the past decade, Markey's prestigious National Cancer Institute designation, combined with the research opportunities it provides, has been a catalyst for growth.
